Chemoinformaics analysis of 1-[(E)-HEX-1-ENYL]CYCLOHEXAN-1-OL
Molecular Weight | 182.307 | nRot | 4 |
Heavy Atom Molecular Weight | 160.131 | nRig | 0 |
Exact Molecular Weight | 182.167 | nRing | 1 |
Solubility: LogS | 0.281 | nHRing | 0 |
Solubility: LogP | 0.903 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 35.5114 |
nHD | 1 | BPOL | 22.0706 |
QED | 0.565 |
Synth | 2.609 |
Natural Product Likeliness | -0.051 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.028 |
HIA | 0.002 |
CACO-2 | -4.29 |
MDCK | 0.0000384 |
BBB | 0.574 |
PPB | 0.207039 |
VDSS | 1.265 |
FU | 0.681585 |
CYP1A2-inh | 0.031 |
CYP1A2-sub | 0.284 |
CYP2c19-inh | 0.029 |
CYP2c19-sub | 0.589 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.061 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.09 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.183 |
CL | 7.405 |
T12 | 0.708 |
hERG | 0.201 |
Ames | 0.08 |
ROA | 0.028 |
SkinSen | 0.362 |
Carcinogencity | 0.308 |
EI | 0.984 |
Respiratory | 0.013 |
NR-Aromatase | 0.053 |
Antiviral | Yes |
Prediction | 0.594887 |